Grace Kim | executive |
Spiro Rombotis | executive |
Mark Kirschbaum | executive |
Paul Mcbarron | executive |
Ahu Demir | analyst |
Jonathan Aschoff | analyst |
Good afternoon, and welcome to the Cyclacel Pharmaceuticals Third Quarter 2023 Results Conference Call and Webcast. [Operator Instructions] Please note today's call is being recorded. I would now like to turn the conference call over to the company. Please go ahead.
Good afternoon, everyone, and thank you for joining today's conference call to discuss Cyclacel's financial results and business highlights for the third quarter of 2023.